Bio Non Operating Income Net Other from 2010 to 2026

BIO Stock  USD 264.93  8.37  3.26%   
Bio Rad Non Operating Income Net Other yearly trend continues to be very stable with very little volatility. Non Operating Income Net Other is likely to grow to about 54.1 M this year. During the period from 2010 to 2026, Bio Rad Non Operating Income Net Other quarterly data regression pattern had sample variance of 345.3 T and median of  22,717,000. View All Fundamentals
 
Non Operating Income Net Other  
First Reported
2011-03-31
Previous Quarter
35.3 M
Current Value
-1.6 B
Quarterly Volatility
B
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Bio Rad financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Rad's main balance sheet or income statement drivers, such as Depreciation And Amortization of 215.7 M, Interest Expense of 51.5 M or Selling General Administrative of 502.6 M, as well as many indicators such as Price To Sales Ratio of 3.36, Dividend Yield of 0.0 or PTB Ratio of 2.1. Bio financial statements analysis is a perfect complement when working with Bio Rad Valuation or Volatility modules.
  
Build AI portfolio with Bio Stock
Check out the analysis of Bio Rad Correlation against competitors.
Evaluating Bio Rad's Non Operating Income Net Other across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Bio Rad Laboratories's fundamental strength.

Latest Bio Rad's Non Operating Income Net Other Growth Pattern

Below is the plot of the Non Operating Income Net Other of Bio Rad Laboratories over the last few years. It is Bio Rad's Non Operating Income Net Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Rad's overall financial position and show how it may be relating to other accounts over time.
Non Operating Income Net Other10 Years Trend
Slightly volatile
   Non Operating Income Net Other   
       Timeline  

Bio Non Operating Income Net Other Regression Statistics

Arithmetic Mean23,759,147
Geometric Mean14,404,053
Coefficient Of Variation78.21
Mean Deviation15,462,743
Median22,717,000
Standard Deviation18,581,589
Sample Variance345.3T
Range53.2M
R-Value0.86
Mean Square Error94.7T
R-Squared0.74
Slope3,171,679
Total Sum of Squares5524.4T

Bio Non Operating Income Net Other History

202654.1 M
202551.5 M
202244.8 M
202124 M
202022.7 M
201923.8 M
201833.7 M

About Bio Rad Financial Statements

Bio Rad investors utilize fundamental indicators, such as Non Operating Income Net Other, to predict how Bio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Non Operating Income Net Other51.5 M54.1 M

Pair Trading with Bio Rad

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bio Stock

  0.87A Agilent Technologies Earnings Call TodayPairCorr
  0.68GSS Genetic Signatures Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.
The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out the analysis of Bio Rad Correlation against competitors.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Will Life Sciences Tools & Services sector continue expanding? Could Bio diversify its offerings? Factors like these will boost the valuation of Bio Rad. Projected growth potential of Bio fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bio Rad data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.83)
Earnings Share
27.84
Revenue Per Share
94.689
Quarterly Revenue Growth
0.039
Return On Assets
0.0167
Bio Rad Laboratories's market price often diverges from its book value, the accounting figure shown on Bio's balance sheet. Smart investors calculate Bio Rad's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Bio Rad's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bio Rad's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bio Rad should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.